CD8A and lung cancer: Additionally, in a humanized-mice model of lung cancer, vaccination with iPSCs + CpG was shown to increase the percentage of splenic APCs and cytotoxic T cells, circulating effector/memory CD4+ and CD8+ T cells and tumor-infiltrating CD8+ T cells, while decreasing Tregs [118] (Table 1).